Scarica l'app Stockscreener
2.03
2.87%
-0.06
Precedente Chiudi:
$2.09
Aprire:
$2.08
Volume 24 ore:
521.15K
Relative Volume:
0.16
Capitalizzazione di mercato:
$53.97M
Reddito:
$155.00K
Utile/perdita netta:
$-30.01M
Rapporto P/E:
-1.2156
EPS:
-1.67
Flusso di cassa netto:
$-11.98M
1 W Prestazione:
-15.77%
1M Prestazione:
-35.76%
6M Prestazione:
-74.14%
1 anno Prestazione:
-70.41%
Intervallo 1D:
$2.03
$2.09
Intervallo di 1 settimana:
$1.94
$2.38
Portata 52W:
$1.89
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Nome
Inmune Bio Inc
Settore
Industria
Telefono
(858) 964-3720
Indirizzo
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Confronta INMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
2.03 | 55.56M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-01 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-21 | Iniziato | Alliance Global Partners | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-01 | Iniziato | Robert W. Baird | Outperform |
| 2022-05-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-21 | Iniziato | B. Riley Securities | Buy |
| 2021-01-22 | Reiterato | Maxim Group | Buy |
| 2020-09-01 | Iniziato | BTIG Research | Buy |
| 2020-07-15 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Inmune Bio Inc Borsa (INMB) Ultime notizie
What technical models suggest about INmune Bio Inc.’s comebackBear Alert & Risk Managed Investment Strategies - Newser
Can you recover from losses in INmune Bio Inc.Earnings Miss & Safe Swing Trade Setups - Newser
What momentum shifts mean for INmune Bio Inc.Quarterly Portfolio Report & Long-Term Capital Growth Strategies - Newser
INmune Bio reverses early gains after stock offering - MSN
What’s next for INmune Bio Inc. stock priceJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - Newser
News impact scoring models applied to INmune Bio Inc.2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Backtesting results for INmune Bio Inc. trading strategiesRisk Management & Weekly Setup with ROI Potential - Newser
Can machine learning forecast INmune Bio Inc. recoveryWeekly Stock Report & Step-by-Step Swing Trade Plans - Newser
What to do if you’re stuck in INmune Bio Inc.Weekly Stock Recap & Consistent Growth Stock Picks - Newser
Can swing trading help recover from INmune Bio Inc. lossesQuarterly Portfolio Summary & Long-Term Safe Investment Plans - Newser
Is INmune Bio Inc. stock reversal real or fakeForecast Cut & Short-Term Trading Alerts - Newser
Is now a turning point for INmune Bio Inc.Portfolio Performance Report & Verified Chart Pattern Signals - Newser
Will a bounce in INmune Bio Inc. offer an exitEarnings Summary Report & Long-Term Growth Plans - Newser
Visual analytics tools that track INmune Bio Inc. performanceEarnings Trend Report & Daily Market Momentum Tracking - Newser
Is INmune Bio Inc. stock entering bullish territoryStop Loss & Stepwise Swing Trade Plans - Newser
Relative strength of INmune Bio Inc. in sector analysisPortfolio Growth Summary & Consistent Return Investment Signals - Newser
Earnings Chart Overlay Points to INmune Bio Inc. Upside getLinesFromResByArray error: size == 0 - kangso.co.kr
Is INmune Bio Inc. stock bottoming out2025 Big Picture & Entry and Exit Point Strategies - Newser
INmune Bio Inc.’s volatility index tracking explainedTrade Analysis Summary & Comprehensive Market Scan Insights - Newser
INmune Bio Inc. stock trend forecast2025 Trading Volume Trends & Reliable Price Action Trade Plans - Newser
Can INmune Bio Inc. rally from current levelsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - Newser
Can INmune Bio Inc. recover in the next quarterJuly 2025 Price Swings & Verified Trade Idea Suggestions - Newser
How high can INmune Bio Inc. stock go2025 Earnings Impact & Fast Moving Stock Watchlists - Newser
Will earnings trigger a reversal in INmune Bio Inc.2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - Newser
Can INmune Bio Inc. hit a new high this monthWeekly Trend Report & AI Powered Market Entry Ideas - Newser
Analyzing INmune Bio Inc. with multi timeframe charts2025 Historical Comparison & Consistent Growth Stock Picks - Newser
Inmune Bio Inc Azioni (INMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inmune Bio Inc Azioni (INMB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tesi Raymond Joseph | President and CEO |
Sep 12 '24 |
Buy |
6.38 |
15,380 |
98,048 |
1,554,106 |
| Moss David J | Chief Financial Officer |
Sep 12 '24 |
Buy |
6.38 |
7,690 |
49,024 |
1,275,869 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):